Group 2:Docetaxel

2 trials

Sponsors

Fujian Tumor Hospital, The First people's Hospital of Yueyang

Conditions

lung squamous cell carcinomasqumous cell lung cancer

Phase 2

Apatinib combined with Docetaxel compared to Docetaxel monotherapy in the treatment of patients with advanced lung squamous cell carcinoma: a prospective, phase II randomized controlled trial

Active, not recruitingChiCTR1800019638

Fujian Tumor Hospitalsqumous cell lung cancer

Start: 2019-01-01Updated: 2018-11-26

Phase II Clinical Study for Anlotinib Combined with Docetaxel in Second-line Treatment of Recurrent or Metastatic Advanced Lung Squamous Cell Carcinoma

Active, not recruitingChiCTR1900020917

The First people's Hospital of Yueyanglung squamous cell carcinoma

Start: 2019-06-01Updated: 2019-01-28